PD-1/PD-L1抑制剂联合抗血管生成药物治疗晚期/不可切慢性乙型病毒性肝炎相关肝细胞癌患者的临床观察Clinical Observation of PD-1/PD-L1 Inhibitors Combined with Anti Angiogenic Drugs in the Treatment of Advanced/Unresectable Chronic Hepatitis B Related Hepatocellular Carcinoma Patients
马永宁, 米日班古丽·买吐地, 唐 勇
临床医学进展Vol.14 No.5, 全文下载: PDF HTML XML DOI:10.12677/acm.2024.1451726, May 31 2024
阿替利珠联合贝伐珠治疗晚期肝癌的安全性及有效性的荟萃分析Meta-Analysis of Safety and Efficacy of Atezolizumab plus Bevacizumab in Advanced Hepatocelluar Carcinoma
田维松, 陈治梁, 余天雾
临床个性化医学Vol.4 No.2, 全文下载: PDF XML DOI:10.12677/jcpm.2025.42151, March 26 2025
阿替利珠单抗联合贝伐珠单抗治疗肝细胞癌的现况Current Status of Atezolizumab Combined with Bevacizumab in the Treatment of HepatocellularCarcinoma
田维松, 余天雾
临床医学进展Vol.14 No.12, 全文下载: PDF XML DOI:10.12677/acm.2024.14123080, December 11 2024
肝动脉灌注化疗及肝动脉化疗栓塞在不可切除性肝细胞癌治疗中的现状及进展Current Status and Progress of Hepatic Artery Perfusion Chemotherapy and Hepatic Artery Chemoembolization in the Treatment of Unresectable Hepatocellular Carcinoma
祖少奇, 杨芳超, 李瑞雪, 朱 磊, 李铁汉, 朱 洪
临床医学进展Vol.15 No.2, 全文下载: PDF XML DOI:10.12677/acm.2025.152413, February 24 2025
免疫检查点抑制剂联合抗血管生成靶向药物治疗晚期肝细胞癌20例临床观察Clinical Observation of Immunotherapy Combined with Antiangiogenic Targeted Drugs in the Treatment of 20 Cases Advanced Hepatocellular Carcinoma
刘 永, 李俐姗, 李红梅, 冷 洁 科研立项经费支持
临床医学进展Vol.13 No.2, 全文下载: PDF HTML XML DOI:10.12677/ACM.2023.132364, February 22 2023
18例不可切除IV期胸腺鳞癌的临床特征及预后分析Analysis of Clinical Characteristics and Prognosis of 18 Cases Unresectable Stage IV Thymic Squamous Cell Carcinoma
寻姝姝, 孟珂心, 陆海军 科研立项经费支持
临床医学进展Vol.14 No.5, 全文下载: PDF HTML XML DOI:10.12677/acm.2024.1451476, May 14 2024